Octalfa

Total investments

22

Average round size

2M

Portfolio companies

13

Rounds per year

1.47

Lead investments

3

Follow on index

0.41

Exits

7

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyFitnessHealth CareWellnessMedical DeviceMedicalLife SciencePharmaceuticalTherapeuticsDental

Summary

Octalfa appeared to be the VC, which was created in 2007. The main department of described VC is located in the u00c9cully. The venture was found in Europe in France.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Octalfa, startups are often financed by Sham Innovation Santu00e9, Pertinence Invest, KREAXI. The meaningful sponsors for the fund in investment in the same round are Sham Innovation Santu00e9, Rhone-Alpes Creation, KREAXI. In the next rounds fund is usually obtained by Sham Innovation Santu00e9, Bpifrance, Sofimac Partners.

The top activity for fund was in 2010. The increased amount of exits for fund were in 2019. Considering the real fund results, this VC is 15 percentage points more often commits exit comparing to other organizations. This Octalfa works on 0 percentage points more the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 investment rounds annually.

We also calculated 2 valuable employees in our database.

Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Pharmaceutical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. Among the most popular portfolio startups of the fund, we may highlight Orega Biotech, Glycode, NightSwapping. The fund has specific favorite in a number of founders of portfolio startups.

Show more

Investments analytics

Analytics

Total investments
22
Lead investments
3
Exits
7
Rounds per year
1.47
Follow on index
0.41
Investments by industry
  • Health Care (16)
  • Medical (12)
  • Biotechnology (11)
  • Pharmaceutical (7)
  • Wellness (6)
  • Show 17 more
Investments by region
  • France (22)
Peak activity year
2012

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
14
Group Appearance index
0.73
Avg. company exit year
10

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
e(ye)BRAIN 09 Oct 2012 Biotechnology, Medical Device, Medical Early Stage Venture 3M Ile-de-France, France, France

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.